Iman El-Hariry
Chief Tech/Sci/R&D Officer en Erytech, Inc. .
Fortuna: - $ al 31/03/2024
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Andrew Sean Holmes | M | 60 |
Imperial College London
| 29 años |
| Yuri Evgenievich Korchev | M | - |
Imperial College London
| 27 años |
| Gokhan Yahioglu | M | - |
Imperial College London
| 27 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Safi R. Bahcall | M | 55 |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 14 años |
| Steven B. Bernitz | M | 78 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 1 años |
| George Farmer | M | - |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | - |
| Amin Elkholy | M | - |
Imperial College London
| 10 años |
| Manos Topoglidis | M | 49 |
Imperial College London
| 5 años |
| Ram Rasaratnam | M | - |
Imperial College London
| 5 años |
| Alan McLean | M | - |
Imperial College London
| 6 años |
| Lan Bo Chen | M | 80 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 11 años |
| Yon-Ho Chong | M | - |
Imperial College London
| 9 años |
| Dvorit Samid | M | - |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | - |
| Paul Friedman | M | 81 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 2 años |
| Christine Redmond | F | - |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | - |
| Zulikat Abiola | M | - |
Imperial College London
| 3 años |
| Hironori Higashide | M | - |
Imperial College London
| 2 años |
| Patrick Verlaine | M | - |
Imperial College London
| 4 años |
| Nainish Bapna | M | - |
Imperial College London
| 4 años |
| Chow Yin Tan | M | 51 |
Imperial College London
| 1 años |
| Elisa Petris | M | 45 |
Imperial College London
| 3 años |
| Peter Sterky | M | - |
Imperial College London
| 1 años |
| Sih Ming Chao | F | 49 |
Imperial College London
| 4 años |
| Konstantinos Vafeiadis | M | 49 |
Imperial College London
| 1 años |
| Khanindra Pathak | M | 64 |
Imperial College London
| 3 años |
| Tze Shyang Puah | M | 53 |
Imperial College London
| 1 años |
| Patrick Alberts | M | 54 |
Imperial College London
| 4 años |
| Shao Dong Wang | M | 61 |
Imperial College London
| 3 años |
| Najla Al Jamali | F | - |
Imperial College London
| 3 años |
| Tommy Chuang | M | - |
Imperial College London
| 4 años |
| Kenneth Fejer | M | - |
Imperial College London
| 4 años |
| Darren Lui | M | 43 |
Imperial College London
| 4 años |
| Chris Evdaimon | M | - |
Imperial College London
| 4 años |
| Jean Marc Anga | M | - |
Imperial College London
| 3 años |
| Dharmendra Magasvaran | M | 47 |
Imperial College London
| 4 años |
| Rebecca Myers | M | - |
Imperial College London
| 3 años |
| Sheung Chi Wu | M | 44 |
Imperial College London
| 4 años |
| Jamil Akbar | M | - |
Imperial College London
| 3 años |
| Elizabeth Klein | F | - |
Imperial College London
| 1 años |
| Lain Roberts | M | - |
Imperial College London
| 2 años |
| Heng Khim Hui | M | - |
Imperial College London
| 3 años |
| Simon Davies | M | - |
Imperial College London
| 4 años |
| David Syriani | M | - |
Imperial College London
| 4 años |
| Bhooshitha B. de Silva | M | 49 |
Imperial College London
| 1 años |
| Stephen Brittain | M | - |
Imperial College London
| 2 años |
| Andrew Eland | M | - |
Imperial College London
| 4 años |
| Yuen Hang Chan | M | 50 |
Imperial College London
| 4 años |
| Baevinraj Thiagarajah | M | 48 |
Imperial College London
| 4 años |
| Hector Jeronimo Dominguis Perez | M | 48 |
Imperial College London
| 4 años |
| Cristina Escoda | M | - |
Imperial College London
| 3 años |
| Sim Siang Leng Nomis | M | - |
Imperial College London
| 3 años |
| Hung Wai Wong | M | 47 |
Imperial College London
| 4 años |
| Anstead Matt | M | 54 |
Imperial College London
| 4 años |
| Jean Philippe Syed | M | - |
Imperial College London
| 5 años |
| Shant Oknayan | M | - |
Imperial College London
| 4 años |
| Ning Loh | M | - |
Imperial College London
| 4 años |
| Sindee Tan | F | - |
Imperial College London
| 4 años |
| Babatunde Temitope Soyoye | M | 55 |
Imperial College London
| 2 años |
| Geoff Maxwell | M | - |
Imperial College London
| 4 años |
| Javier Rodriguez-Alarcon | M | - |
Imperial College London
| 1 años |
| Michael Tobias Stumpp | M | 52 |
Imperial College London
| 1 años |
| Nilay Shah | M | - |
Imperial College London
| 1 años |
| Ahmet Sener | M | 48 |
Imperial College London
| 1 años |
| Max Reis | M | 96 |
Imperial College London
| 3 años |
| Bozena Maria Jankowska | F | - |
Imperial College London
| 1 años |
| Uzoma Chukwumaeze Dozie | M | 55 |
Imperial College London
| 2 años |
| Dennis Nadarajah | M | - |
Imperial College London
| 4 años |
| Allan Jaenicke | M | - |
Imperial College London
| 4 años |
| Satu Vainikka | M | 56 |
Imperial College London
| 2 años |
| Jonathan Ng | M | - |
Imperial College London
| 4 años |
| Cristiano Ceccato | M | - |
Imperial College London
| 1 años |
| Edward Stuart | M | - |
Imperial College London
| 2 años |
| Keizo Koya | M | 66 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 10 años |
| Ian M. Gregory | M | 50 |
Imperial College London
| 1 años |
| Charlie Thomas | M | - |
Imperial College London
| 1 años |
| José T. de Sousa | M | - |
Imperial College London
| 3 años |
| Astorre Modena | M | 54 |
Imperial College London
| 4 años |
| Robert Taylor | M | - |
Imperial College London
| 3 años |
| Sally Duckworth | F | 56 |
Imperial College London
| 1 años |
| Xing Hua Wu | M | 61 |
Imperial College London
| 1 años |
| Sumant Ramachandra | M | 55 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | - |
| Marion Bush | F | - |
Imperial College London
| 1 años |
| Samuel Paul Oliver Carew-Jones | M | 49 |
Imperial College London
| 4 años |
| Yida Kemoli | M | 44 |
Imperial College London
| 4 años |
| Thomas J. Wilson | M | - |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | - |
| Wai Mun Woo | M | 49 |
Imperial College London
| 1 años |
| Nathan Wong | M | - |
Imperial College London
| 4 años |
| Amanda Jean-Baptiste | F | - |
Imperial College London
| 1 años |
| Man Chiu Rudolf Yu | M | 50 |
Imperial College London
| 4 años |
| Philip Harris | M | - |
Imperial College London
| 2 años |
| Lakshman Dhammika Karalliedde | M | 83 |
Imperial College London
| 2 años |
| Khuram Chaudhry | M | - |
Imperial College London
| 4 años |
| Zouhair Belkoura | M | - |
Imperial College London
| 4 años |
| Andreas Michalopoulos | M | 53 |
Imperial College London
| 1 años |
| Vijay Curthan | M | - |
Glaxo Smith Kline Biologicals NA
 Glaxo Smith Kline Biologicals NA Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Glaxo Smith Kline Biologicals NA is an American pharmaceutical company that manufactures pharmaceutical products. | 2 años |
| Hin Sun Wong | M | 56 |
Imperial College London
| 2 años |
| Ian Poccachard | M | - |
Imperial College London
| 1 años |
| Daniel Rueckert | M | 55 |
Imperial College London
| 3 años |
| Emmanuel Papadakis | M | - |
Imperial College London
| 3 años |
| Mayer Ferdinand | M | - |
Imperial College London
| 3 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Reino Unido | 89 | 89.00% |
| Estados Unidos | 11 | 11.00% |
| Japón | 0 | -.--% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Iman El-Hariry
- Red Personal
